Fredrik Schjesvold is Head of Oslo Myeloma Center, in Oslo, Norway. He is head of the Norwegian myeloma association; president of the Nordic Myeloma Study Group and a member of the European Myeloma Network board. He is national investigator of 39 clinical trials in multiple myeloma, and principal investigator for 4 academic trials. He is a co-author of ESMO and IMWG guidelines, and lead author of the Norwegian myeloma guidelines. He is peer-reviewer of several international journals, and co-editor of the journal Hemato. He is an international expert on myeloma and has given talks in Europe, America and Asia.
EM-93998 - Date of preparation: March 2022